Literature DB >> 33741014

Minimally invasive closure of transthoracic ventricular septal defect: postoperative complications and risk factors.

Chunnian Ren1,2,3, Chun Wu1,2,3, Zhengxia Pan1,2,3, Yonggang Li4,5,6.   

Abstract

OBJECTIVES: To summarize and analyze the clinical characteristics of postoperative complications after minimally invasive closure of transthoracic ventricular septal defect, and to explore the risk factors for its occurrence.
METHODS: Retrospectively analyzed the clinical data of 209 patients underwent transthoracic ventricular septal defect closure performed in the Department of Cardiothoracic Surgery, Children's Hospital of Chongqing Medical University from January 2018 to January 2020, obtained relevant clinical data from the electronic medical record system and summarized their postoperative complications. And used univariate logistics regression and multivariate logistics regression to analyze the risk factors of its occurrence.
RESULTS: The postoperative hospital stay of 27 patients was longer than 9 days. Residual shunt occurred in 33 patients recently after operation. One patient underwent surgical treatment again because of mechanical hemolysis after the operation. Two patients were re-operated 1 month and 10 months after surgery because of persistent moderate to severe aortic regurgitation. After surgery, 3 patients underwent pericardiocentesis due to a large amount of pericardial effusion, and 2 patients developed a new atrioventricular block after the operation. No other serious adverse events occurred. Multivariate logistic regression analysis showed that the size of VSD defect (OR: 1.494, 95% Cl: 1.108-2.013, P value: 0.008) was related to long postoperative hospitalization. The residual shunt is related to the size of the occluder (OR: 1.452, 95%Cl: 1.164-1.810, P value: 0.001). In the univariate logistics regression analysis, no risk factors related to serious adverse events were found.
CONCLUSIONS: The minimally invasive closure of transthoracic ventricular septal defect is very effective, with no mortality and low incidence of serious adverse events after surgery. The size of the defect is related to the long postoperative hospitalization, and the size of the occluder is related to the residual shunt in the early postoperative period. No risk factors related to the occurrence of serious adverse events after the operation were found.

Entities:  

Keywords:  Cardiac intervention; Congenital heart diseases; Risk factors; Surgery; Ventricular septal defect

Mesh:

Year:  2021        PMID: 33741014      PMCID: PMC7980643          DOI: 10.1186/s13019-021-01415-z

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  15 in total

1.  Perventricular device closure of ventricular defects in 235 young children: a single-center experience.

Authors:  Hua-Shan Xu; Kamran Yunus Inamdar; Khan Mohammed Firoj; Wen-Zeng Zhao
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-24       Impact factor: 5.209

2.  Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect.

Authors:  Gianfranco Butera; Chessa Massimo; Carminati Mario
Journal:  Catheter Cardiovasc Interv       Date:  2006-06       Impact factor: 2.692

3.  Intraoperative Device Closure of Isolated Ventricular Septal Defects: Experience on 1,090 Cases.

Authors:  Qiang Chen; Zhi-Nuan Hong; Gui-Can Zhang; Liang-Wan Chen; Qi-Liang Zhang; Ze-Wei Lin; Hua Cao
Journal:  Ann Thorac Surg       Date:  2018-03-27       Impact factor: 4.330

4.  Contemporary outcomes of surgical ventricular septal defect closure.

Authors:  Brett R Anderson; Kristen N Stevens; Susan C Nicolson; Stephen B Gruber; Thomas L Spray; Gil Wernovsky; Peter J Gruber
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03       Impact factor: 5.209

5.  Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects.

Authors:  M A Walsh; J Bialkowski; M Szkutnik; M Pawelec-Wojtalik; W Bobkowski; K P Walsh
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

6.  Treatment of Perimembranous Ventricular Septal Defect in Children Weighing Less than 15 kg: Minimally Invasive Periventricular Device Occlusion versus Right Subaxillary Small Incision Surgical Repair.

Authors:  Xueqin Zhang; Quansheng Xing; Qin Wu
Journal:  Thorac Cardiovasc Surg       Date:  2015-03-13       Impact factor: 1.827

7.  Perventricular closure of perimembranous ventricular septal defects using the concentric occluder device.

Authors:  Shunmin Wang; Zhongyun Zhuang; Haibo Zhang; Jinhao Zhen; Yanan Lu; Jinfen Liu; Zhiwei Xu
Journal:  Pediatr Cardiol       Date:  2013-11-07       Impact factor: 1.655

8.  An empirically based tool for analyzing morbidity associated with operations for congenital heart disease.

Authors:  Marshall L Jacobs; Sean M O'Brien; Jeffrey P Jacobs; Constantine Mavroudis; Francois Lacour-Gayet; Sara K Pasquali; Karl Welke; Christian Pizarro; Felix Tsai; David R Clarke
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-24       Impact factor: 5.209

9.  Atrioventricular block: a serious complication in and after transcatheter closure of perimembranous ventricular septal defects.

Authors:  Tao Zhou; Xiang-Qian Shen; Sheng-Hua Zhou; Zhen-Fei Fang; Xin-Qun Hu; Yan-Shu Zhao; Shu-Shan Qi; Zheng Zhou; Jiang Li; Xiao-Lin Lv
Journal:  Clin Cardiol       Date:  2008-08       Impact factor: 2.882

10.  Residual Shunts Following Isolated Surgical Ventricular Septal Defect Closure: Risk Factors and Spontaneous Closure.

Authors:  Xicheng Deng; Peng Huang; Jinwen Luo; Renwei Chen; Guangxian Yang; Wenjuan Chen; Qianjun Liu; Cheng He
Journal:  Pediatr Cardiol       Date:  2019-10-24       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.